Agilon Health (NYSE:AGL) Shares Down 5.6% – Here’s Why

Agilon Health, Inc. (NYSE:AGL)’s share price dropped 5.6% during trading on Monday . The company traded as low as $87.45 and last traded at $87.35. Approximately 46,944 shares changed hands during trading, a decline of 87% from the average session volume of 347,975 shares. The stock had previously closed at $92.54.

Analyst Upgrades and Downgrades

AGL has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and upped their target price for the company from $33.00 to $49.00 in a research report on Thursday, May 7th. TD Cowen reiterated a “hold” rating and set a $55.00 price objective (up from $17.00) on shares of Agilon Health in a research note on Monday, May 11th. Weiss Ratings reissued a “sell (e+)” rating on shares of Agilon Health in a report on Monday, August 24th. Truist Financial set a $112.00 price target on shares of Agilon Health and gave the stock a “hold” rating in a report on Thursday, August 6th. Finally, Benchmark reiterated a “buy” rating and set a $140.00 price target (up from $95.00) on shares of Agilon Health in a research report on Thursday, August 6th. Five analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Agilon Health presently has a consensus rating of “Hold” and a consensus target price of $97.70.

Agilon Health Stock Down 0.7%

The firm has a 50 day moving average of $103.14 and a two-hundred day moving average of $64.98. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of -6.12 and a beta of 3.02. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.07.

Agilon Health (NYSE:AGL) last issued its earnings results on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, topping the consensus estimate of $0.14 by $0.90. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%.The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.45 billion. As a group, sell-side analysts anticipate that Agilon Health, Inc. will post -2.33 EPS for the current fiscal year.

Institutional Trading of Agilon Health

A number of hedge funds have recently added to or reduced their stakes in AGL. Rubicon Founders LLC acquired a new position in shares of Agilon Health during the second quarter worth $11,290,448. Great Lakes Advisors LLC bought a new stake in Agilon Health during the 2nd quarter worth $702,000. Alpine Global Management LLC acquired a new position in Agilon Health in the 4th quarter worth about $84,000. LPL Financial LLC raised its position in Agilon Health by 213.4% in the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after purchasing an additional 30,000 shares during the last quarter. Finally, Corient Private Wealth LP bought a new position in Agilon Health in the second quarter valued at about $406,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.